C229 - Emerging Therapies in Epilepsy

Event Time: Friday April 28, 2017 7:00 am to 9:00 am
Topic(s): Epilepsy/Clinical Neurophysiology (EEG)
Director(s): Daniel Friedman MD
Description: Despite the availability of over 20 anti-seizure drugs, about 30 percent of people with epilepsy cannot achieve complete seizure control on available therapy, and many more experience side-effects of their treatment. Treatment gaps also exist in the management of status epilepticus; many patients fail to respond to first- or second-line treatments. This program will review some of the latest advances in the medical and surgical treatment of epilepsy. Faculty will provide the latest information about the potential efficacy and safety of cannabinoids for epilepsy treatment to help clinicians have evidence-based discussions with patients and family as medical cannabis becomes more widely available. Faculty will also discuss advances in surgical approaches that are less invasive than traditional epilepsy surgery and could increase the number of patients who can benefit from this approach. Finally, we will discuss novel treatments for status epilepticus that may improve patient outcomes in this neurologic emergency.
Completion Message: Participants should be able to have greater understanding of the current evidence to support the safety and efficacy of various cannabinoids for epilepsy treatment as well as potential interactions with anti-seizure drugs. Participants will also become familiar with new approaches to surgical treatment of epilepsy including laser ablation, stereotactic radiosurgery, and ultrasound-based therapies; learn about the evidence supporting these new modalities and which patients may be appropriate these new options; and understand new treatments for status epilepticus, including out-of-hospital therapies and strategies for management of refractory status epilepticus.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care

Register Now

Related Courses